Sort
21,281 grants matching “influenza”
Collaborative Research: DMREF: Predicting Molecular Interactions to Stabilize Viral Therapies
$568,044Caryn Heldt · Michigan Technological University · · FY2021 · MPS
Modeling the Coupled Dynamics of COVID-19 Transmission and Protective Behaviors
$567,938Raffaele Vardavas · Rand Corporation · R01 · FY2022 · AI
Development of innovative therapeutics for otitis media
$567,783Jian-Dong Li · Georgia State University · R01 · FY2022 · DC
Collaborative Research: DMREF: Predicting Molecular Interactions to Stabilize Viral Therapies
$567,653Sapna Sarupria · University Of Minnesota-Twin Cities · · FY2023 · MPS
Collaborative Research: DMREF: Predicting Molecular Interactions to Stabilize Viral Therapies
$567,653Sapna Sarupria · Clemson University · · FY2021 · MPS
Induction of Immunity by Influenza Virus
$567,511Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2007 · AI
High-resolution single cell profiling of vaccine responsiveness in the elderly
$567,504Jacques F Banchereau · Jackson Laboratory · R01 · FY2021 · AI
Characterization of the Evolution of Influenza A Viruses
$567,491National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$567,476Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2018 · AI
Harnessing Natural Killer T cells to counteract swine influenza
$567,403John Driver · University Of Florida · R01 · FY2017 · HD
Induction of Immunity by Influenza Virus
$567,258Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2008 · AI
Novel Therapeutic Approach to Acute Lung Injury
$567,237Sutip Navankasattusas · Navigen, Inc. · R44 · FY2011 · HL
Innate DC Govern TH Polarization through the Novel Regulator AIMp1
$567,195William Karl Decker · Baylor College Of Medicine · R01 · FY2021 · AI
Long-term durability of DENV-specific immunity after vaccination in a dengue-endemic population
$567,169Alan L Rothman · University Of Rhode Island · U01 · FY2025 · AI
Long-term durability of DENV-specific immunity after vaccination in a dengue-endemic population
$567,169Alan L Rothman · University Of Rhode Island · U01 · FY2024 · AI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
$567,150Sumit K Chanda · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
Integrative analysis and modeling of human immune responses and pathologies
$567,109John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Influence of maternal antibodies on a Sendai virus-vectored RSV vaccine
$566,924Julia L Hurwitz · St. Jude Children'S Research Hospital · R01 · FY2014 · AI
Role of innate immune responses in the activity of an Alphavirus based adjuvant.
$566,898Robert E. Johnston · Global Vaccines, Inc. · R01 · FY2012 · AI
Role of innate immune responses in the activity of an Alphavirus based adjuvant.
$566,898Robert E. Johnston · Global Vaccines, Inc. · R01 · FY2014 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$566,883Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2021 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants
$566,874Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2019 · AI
Alcohol Use Trajectories and Prevention: A US-Sweden Comparison
$566,868Mary E Larimer · University Of Washington · U01 · FY2010 · AA
Viral pathogenesis of chronic inflammatory lesions of the placenta
$566,770Kristine M. Wylie · Washington University · R01 · FY2022 · HD
Systems biological analyses of innate responses to vaccination
$566,752Bali Pulendran · Emory University · U19 · FY2014 · AI